{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:54:27Z","timestamp":1792673667069,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["Study funding"],"award-info":[{"award-number":["Study funding"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","award":["Funding for analysis"],"award-info":[{"award-number":["Funding for analysis"]}],"id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","award":["medical writing"],"award-info":[{"award-number":["medical writing"]}],"id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","award":["publication fees"],"award-info":[{"award-number":["publication fees"]}],"id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","award":["Funding for medical writing"],"award-info":[{"award-number":["Funding for medical writing"]}],"id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40120-023-00569-3","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T11:01:56Z","timestamp":1704366116000},"page":"165-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Etsuko","family":"Awaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Matsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-5191","authenticated-orcid":false,"given":"Naoki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3733-7411","authenticated-orcid":false,"given":"Ryo","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-2469","authenticated-orcid":false,"given":"Satoshi","family":"Osaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5014-2483","authenticated-orcid":false,"given":"Yoshinori","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-1296","authenticated-orcid":false,"given":"Mika","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"issue":"1","key":"569_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"1","key":"569_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z, on behalf of Lifting The Burden: the Global Campaign against Headache. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137.","journal-title":"J Headache Pain"},{"issue":"7","key":"569_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646\u201357.","journal-title":"Headache"},{"issue":"5","key":"569_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"},{"issue":"1","key":"569_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40120-021-00305-9","volume":"11","author":"Y Matsumori","year":"2022","unstructured":"Matsumori Y, Ueda K, Komori M, et al. Burden of migraine in Japan: results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Neurol Ther. 2022;11(1):205\u201322.","journal-title":"Neurol Ther"},{"issue":"1","key":"569_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-020-01180-9","volume":"21","author":"S Kikui","year":"2020","unstructured":"Kikui S, Chen Y, Todaka H, Asao K, Adachi K, Takeshima T. Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey. J Headache Pain. 2020;21(1):110.","journal-title":"J Headache Pain"},{"issue":"11","key":"569_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038987","volume":"10","author":"H Igarashi","year":"2020","unstructured":"Igarashi H, Ueda K, Jung S, Cai Z, Chen Y, Nakamura T. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open. 2020;10(11): e038987.","journal-title":"BMJ Open"},{"issue":"1","key":"569_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-019-1012-1","volume":"20","author":"K Ueda","year":"2019","unstructured":"Ueda K, Ye W, Lombard L, et al. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain. 2019;20(1):68.","journal-title":"J Headache Pain"},{"key":"569_CR9","first-page":"A89","volume":"68","author":"DC Buse","year":"2007","unstructured":"Buse DC, Bigal MB, Rupnow M, Reed ML, Serrano D, Lipton R. Development and validation of the Migraine Interictal Burden Scale (MIBS): a self-administered instrument for measuring the burden of migraine between attacks [abstract S05.003]. Neurology. 2007;68:A89.","journal-title":"Neurology"},{"issue":"5","key":"569_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0025-6196(11)60561-2","volume":"84","author":"DC Buse","year":"2009","unstructured":"Buse DC, Rupnow MFT, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84(5):422\u201335.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"569_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631\u201349.","journal-title":"Neurol Clin"},{"issue":"11","key":"569_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1080\/03007995.2021.1971179","volume":"37","author":"K Hirata","year":"2021","unstructured":"Hirata K, Ueda K, Komori M, et al. Comprehensive population-based survey of migraine in Japan: results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Curr Med Res Opin. 2021;37(11):1945\u201355.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"569_CR13","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1007\/s12325-022-02289-w","volume":"39","author":"T Takeshima","year":"2022","unstructured":"Takeshima T, Ueda K, Komori M, et al. Potential unmet needs in acute treatment of migraine in Japan: results of the OVERCOME (Japan) study. Adv Ther. 2022;39(11):5176\u201390.","journal-title":"Adv Ther"},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40801-023-00368-0","volume":"10","author":"K Hirata","year":"2023","unstructured":"Hirata K, Komori M, Ueda K, et al. Outcomes and factors associated with insufficient effectiveness of acute treatments of migraine in Japan: results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Drugs Real World Outcomes. 2023;10:415\u201328.","journal-title":"Drugs Real World Outcomes."},{"issue":"3","key":"569_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1468-2982.2006.01275.x","volume":"27","author":"S Silberstein","year":"2007","unstructured":"Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007;27(3):220\u20139.","journal-title":"Cephalalgia"},{"issue":"6 Suppl 1","key":"569_CR16","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138.","journal-title":"Neurology"},{"issue":"4","key":"569_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1526-4610.2003.03069.x","volume":"43","author":"M Iigaya","year":"2003","unstructured":"Iigaya M, Sakai F, Kolodner KB, Lipton RB, Stewart WF. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache. 2003;43(4):343\u201352.","journal-title":"Headache"},{"issue":"3","key":"569_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1526-4610.2000.00030.x","volume":"40","author":"BC Martin","year":"2000","unstructured":"Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache. 2000;40(3):204\u201315.","journal-title":"Headache"},{"issue":"8","key":"569_CR19","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1023\/B:QURE.0000040787.20364.89","volume":"13","author":"S Ohbu","year":"2004","unstructured":"Ohbu S, Igarashi H, Okayasu H, et al. Development and testing of the Japanese version of the migraine-specific quality of life instrument. Qual Life Res. 2004;13(8):1489\u201393.","journal-title":"Qual Life Res"},{"issue":"4","key":"569_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/head.13028","volume":"57","author":"RB Lipton","year":"2017","unstructured":"Lipton RB, Buse DC, Adams AM, Varon SF, Fanning KM, Reed ML. Family impact of migraine: development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) scale. Headache. 2017;57(4):570\u201385.","journal-title":"Headache"},{"issue":"12","key":"569_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.5692\/clinicalneurol.cn-001903","volume":"63","author":"T Takeshima","year":"2023","unstructured":"Takeshima T, Ooba S, Hanaoka Y, et al. Impact of migraine on family members: an investigation by Impact of Migraine on Partners and Adolescent Children (IMPAC) scale. Rinsho Shinkeigaku. 2023;63(12):813\u201323. (in Japanese)","journal-title":"Rinsho Shinkeigaku."},{"issue":"1\u20133","key":"569_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","volume":"114","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1\u20133):163\u201373.","journal-title":"J Affect Disord"},{"issue":"3 Pt 1","key":"569_CR23","first-page":"952","volume":"101","author":"K Muramatsu","year":"2007","unstructured":"Muramatsu K, Miyaoka H, Kamijima K, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep. 2007;101(3 Pt 1):952\u201360.","journal-title":"Psychol Rep"},{"issue":"10","key":"569_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"3 Suppl 1","key":"569_CR25","first-page":"79","volume":"51","author":"K Muramatsu","year":"2009","unstructured":"Muramatsu K, Muramatsu Y, Miyaoka H, et al. Validation and utility of a Japanese version of the GAD-7. Panminerva Medica 20th World Congress on Psychosomatic Medicine. Abstract book. 2009;51(3 Suppl 1):79.","journal-title":"Abstract book."},{"issue":"1","key":"569_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1526-4610.2004.04004.x","volume":"44","author":"T Takeshima","year":"2004","unstructured":"Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache. 2004;44(1):8\u201319.","journal-title":"Headache"},{"issue":"1","key":"569_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s10194-022-01439-3","volume":"23","author":"F Sakai","year":"2022","unstructured":"Sakai F, Hirata K, Igarashi H, et al. A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan. J Headache Pain. 2022;23(1):70.","journal-title":"J Headache Pain"},{"issue":"16","key":"569_CR28","first-page":"00126","volume":"S0025\u20136196","author":"DC Buse","year":"2016","unstructured":"Buse DC, Scher AI, Dodick DW, et al. Impact of migraine on the family: perspectives of people with migraine and their spouse\/domestic partner in the CaMEO study. Mayo Clin Proc. 2016;S0025\u20136196(16):00126\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"569_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/head.13716","volume":"60","author":"SJ Tepper","year":"2020","unstructured":"Tepper SJ, Silberstein SD, Rosen NL, et al. The influence of migraine on driving: current understanding, future directions, and potential implications of findings. Headache. 2020;60(1):178\u201389.","journal-title":"Headache"},{"key":"569_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.955298","volume":"13","author":"S Duan","year":"2022","unstructured":"Duan S, Ren Z, Xia H, Wang Z, Zheng T, Liu Z. Association between sleep quality, migraine and migraine burden. Front Neurol. 2022;13:955298.","journal-title":"Front Neurol"},{"issue":"5","key":"569_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1212\/WNL.55.5.629","volume":"55","author":"RB Lipton","year":"2000","unstructured":"Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: a population-based case-control study. Neurology. 2000;55(5):629\u201335.","journal-title":"Neurology"},{"issue":"9","key":"569_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/0333102416653235","volume":"37","author":"TJ Song","year":"2017","unstructured":"Song TJ, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK. Anxiety and depression in probable migraine: a population-based study. Cephalalgia. 2017;37(9):845\u201354.","journal-title":"Cephalalgia"},{"issue":"9","key":"569_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/pcn.13105","volume":"74","author":"M Ueda","year":"2020","unstructured":"Ueda M, Stickley A, Sueki H, Matsubayashi T. Mental health status of the general population in Japan during the COVID-19 pandemic. Psychiatry Clin Neurosci. 2020;74(9):505\u20136.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"569_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","volume":"22","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Sakai F, Miyake H, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021;22(1):29.","journal-title":"J Headache Pain"},{"issue":"4","key":"569_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/0333102419885394","volume":"40","author":"J Wolf","year":"2020","unstructured":"Wolf J, Danno D, Takeshima T, Vancleef LM, Yoshikawa H, Gaul C. The relation between emotion regulation and migraine: a cross-cultural study on the moderating effect of culture. Cephalalgia. 2020;40(4):384\u201392.","journal-title":"Cephalalgia"},{"key":"569_CR36","unstructured":"Cerner Enviza. Stigma (ELICIT mini series\u2014Issue 1). Cerner Corporation; 2022."},{"issue":"1","key":"569_CR37","first-page":"135","volume":"50","author":"E Awaki","year":"2023","unstructured":"Awaki E. Migraine treatment that takes gender differences into account. Jpn J Headache. 2023;50(1):135\u20139 (in Japanese).","journal-title":"Jpn J Headache"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00569-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T14:13:04Z","timestamp":1705155184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00569-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00569-3","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Etsuko Awaki reports lecture fees\/honoraria from Amgen, Daiichi Sankyo Company, Limited, Eli Lilly Japan K.K., and Otsuka Pharmaceutical Co., Ltd. Takao Takeshima received research funding\/collaborative research expenses from Biohaven, Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Lundbeck Japan K.K., and Shionogi & Co., Ltd., and reports personal fees from Amgen Astellas BioPharma K.K., Daiichi Sankyo Company, Limited, Eli Lilly Japan K.K., and Otsuka Pharmaceutical Co., Ltd. Takao Takeshima also acted as an advisor to Hedgehog MedTech, Inc. and Sawai Pharmaceutical Co., Ltd. Yasuhiko Matsumori reports personal consultancy fees from Amgen Astellas BioPharma K.K., Daiichi Sankyo Company, Limited, Eli Lilly Japan K.K., and Otsuka Pharmaceutical Co., Ltd. during the conduct of the study. Koichi Hirata received research funding from the Japanese Ministry of Health, Labour and Welfare and the Japan Agency for Medical Research and Development, and reports personal fees from AbbVie GK, Amgen Astellas BioPharma K.K., Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Eli Lilly Japan K.K., MSD Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., and Sawai Pharmaceutical Co., Ltd. Naoki Miyazaki and Ryo Takemura are employees of Keio University. Keio University received funding from Eli Lilly Japan K.K. for the statistical analyses reported in this manuscript. Satoshi Osaga, Yoshinori Tanizawa, and Mika Komori are employees of Eli Lilly Japan K.K. and own minor shares in Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was granted ethical approval by the Research Institute of Healthcare Data Science Ethical Review Board (ID: RI2020003), and electronic informed consent was obtained from all respondents. All data were anonymized before analysis. This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}